ArticleRadiation oncology (London, England)2018
Imaging dose and secondary cancer risk in image-guided radiotherapy of pediatric patients.
Article in Radiation oncology (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 40 citations in OpenAlex.
- Optimization of CBCT-guided imaging schedules for left-sided postmastectomy radiotherapy using VMAT: A dosimetric, radiobiological, and cost analysis.Journal of applied clinical medical physics · 2026Article
- Commissioning of LUNA three-dimensional surface-guided radiotherapy in full rotating gantry proton therapy system.International journal of particle therapy · 2026Article
- Research on real-time detection of radiotherapy setup errors and intelligent quality control methods based on artificial intelligence and big data.Frontiers in oncology · 2026Article
- Organ-specific low-dose assessment in pediatric radiotherapy using nanodot OSL and NTCP modeling: Application to medulloblastoma.Journal of applied clinical medical physics · 2026Article
- Use of diagnostic vs low-dose computed tomography in positron emission tomography-CT examinations.European radiology · 2025Article
- Positioning in deep inspiration breath-hold is comparable to free breathing in paediatric patients.Clinical and translational radiation oncology · 2025Article
- Investigation of the beam width and profile of kilovoltage CBCT using different measurement techniques and analysis of the dosimetric effects of beam parameters.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025Article
- Unsupervised Deep Learning for Synthetic CT Generation from CBCT Images for Proton and Carbon Ion Therapy for Paediatric Patients.Sensors (Basel, Switzerland) · 2024Article
- Combined biological effects of CBCT and therapeutic X-ray dose on chromosomal aberrations of lymphocytes.Radiation oncology (London, England) · 2024Article
- Virtual clinical trial-based study for clinical evaluation of projection-reduced low-dose cone-beam CT for image guided radiotherapy.Frontiers in oncology · 2024Article
- Image guidance and interfractional anatomical variation in paediatric abdominal radiotherapy.The British journal of radiology · 2023Article
- Towards Accurate and Precise Image-Guided Radiotherapy: Clinical Applications of the MR-Linac.Journal of clinical medicine · 2022Review
- Initial clinical experience of surface guided stereotactic radiation therapy with open-face mask immobilization for improving setup accuracy: a retrospective study.Radiation oncology (London, England) · 2022Article
- Comparison of Breast Cancer Radiotherapy Techniques Regarding Secondary Cancer Risk and Normal Tissue Complication Probability - Modelling and Measurements Using a 3D-Printed Phantom.Frontiers in oncology · 2022Article
- Evaluation of a new acrylic-lead shielding device for peripheral dose reduction during cone-beam computed tomography.BJR open · 2022Article
- Impact of CBCT frequency on target coverage and dose to the organs at risk in adjuvant breast cancer radiotherapy.Scientific reports · 2021Article
- Out-of-field dose in stereotactic radiotherapy for paediatric patients.Physics and imaging in radiation oncology · 2021Article
- Contribution of Imaging to Organs at Risk Dose during Lung Stereotactic Body Radiation Therapy.Journal of biomedical physics & engineering · 2021Article
- How low can you go? A CBCT dose reduction study.Journal of applied clinical medical physics · 2021Article
- Evaluation of patient organ doses from kilovoltage cone-beam CT imaging in radiation therapy.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDaily image-guided radiotherapy (IGRT) can contribute to cover extended body volumes with low radiation dose. The effect of additional imaging dose on secondary cancer development is modelled for a collective of children with Morbus Hodgkin.
methodsEleven radiotherapy treatment plans from pediatric patients with Hodgkin's lymphoma were retrospectively analyzed, including imaging dose from scenarios using different energies (kV/MV) and planar/cone-beam computed tomography (CBCT) techniques. In addition to assessing the effect of imaging dose on organs at risk, the excess average risk (EAR) for developing a secondary carcinoma of the lung or breast was modelled.
resultsAlthough the variability between the patients is relatively large due to the different target volumes, the additional EAR due to imaging can be consistently determined. For daily 6MV CBCT, the EAR for developing a secondary cancer at age 50 is over 3 cases per 10
conclusionsDaily imaging can be performed with an additional secondary cancer risk of less than 1 per 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.